New local anesthetics: Are they worth the cost?

Anesthesiology Clinics of North America

Volumn 21, Issue 1, 2003, Pages 19-38

  Panni, Moeen ^a   Segal, Scott ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; FENTANYL; LEVOBUPIVACAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MIDAZOLAM; ROPIVACAINE;

ANESTHESIA MECHANISM; BRADYCARDIA; CARDIOTOXICITY; CESAREAN SECTION; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG COST; DRUG POTENCY; DRUG STRUCTURE; EPIDURAL ANESTHESIA; GRAND MAL EPILEPSY; HEART ARRHYTHMIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LOCAL ANESTHESIA; META ANALYSIS; NEUROTOXICITY; NONHUMAN; OBSTETRIC ANALGESIA; OBSTETRIC ANESTHESIA; QRS COMPLEX; REVIEW; STEREOCHEMISTRY; STRUCTURE ANALYSIS; TACHYPHYLAXIS; TINNITUS; TOXICITY; VERTIGO;

AMIDES; ANALGESIA, EPIDURAL; ANALGESIA, OBSTETRICAL; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; FEMALE; HUMANS; NERVE BLOCK; PREGNANCY;

EID: 0037350907     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8537(02)00032-9     Document Type: Article

References (69)

1. Reynolds F, Taylor G. Plasma concentrations of bupivacaine during continuous epidural analgesia in labour: the effect of adrenaline. Br J Anaesth 1971;43:436-40.
2. Choi RH, Birknes JK, Popitz-Bergez FA, et al. Pharmacokinetic nature of tachyphylaxis to lidocaine: peripheral nerve blocks and infiltration anesthesia in rats. Life Sci 1997;61:177-84.
3. Valenzuela C, Snyders DJ, Bennett PB, et al. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation 1995;92:3014-24.
4. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979;51:285-7.
5. Clarkson CW, Hondeghem LM. Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 1985;62:396-405.
6. Arlock P. Actions of three local anaesthetics: lidocaine, bupivacaine and ropivacaine on guinea pig papillary muscle sodium channels (Vmax). Pharmacol Toxicol 1988;63:96-104.
7. Block A, Covino BG. Effect of local anesthetic agents on cardiac conduction and contractility. Reg Anesth 1981;6:55-61.
8. Avery P, Redon D, Schaenzer G, et al. The influence of serum potassium on the cerebral and cardiac toxicity of bupivacaine and lidocaine. Anesthesiology 1984;61:134-8.
9. Wheeler DM, Bradley EL, Woods Jr. WT. The electrophysiologic actions of lidocaine and bupivacaine in the isolated, perfused canine heart. Anesthesiology 1988;68:201-12.
10. Valenzuela C, Delpon E, Tamkun MM, et al. Stereoselective block of a human cardiac potassium channel (Kvl.5) by bupivacaine enantiomers. Biophys J 1995;69:418-27.
11. Vanhoutte F, Vereecke J, Verbeke N, et al. Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle. Br J Pharmacol 1991;103:1275-81.
12. Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993;77:477-82.
13. Graf BM, Martin E, Bosnjak ZJ, et al. Stereospecific effect of bupivacaine isomers on atrioventricular conduction in the isolated perfused guinea pig heart. Anesthesiology 1997;86:410-9.
14. Denson DD, Behbehani MM, Gregg RV. Effects of an intravenously administered arrhythmogenic dose of bupivacaine at the nucleus tractus solitarius in the conscious rat. Reg Anesth 1990; 15:76-80.
15. Denson DD, Behbehani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992; 17:311-6.
16. Huang YF, Pryor ME, Mather LE, et al. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998;86:797-804.
17. Mather LE, Huang YF, Veering B, et al. Systemic and regional pharmacokinetics of levobupivacaine and bupivacaine enantiomers in sheep. Anesth Analg 1998;86:805-11.
18. Chang DH, Ladd LA, Copeland S, et al. Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep. Br J Pharmacol 2001;132:649-58.
19. Morrison SG, Dominguez JJ, Frascarolo P, et al. A comparison of the electrocardiographic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine. Anesth Analg 2000;90:1308-14.
20. Santos AC, DeArmas PI. Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes. Anesthesiology 2001;95:1256-64.
21. Feldman HS, Arthur GR, Pitkanen M, et al. Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth Analg 1991;73:373-84.
22. Groban L, Deal DD, Vernon JC, et al. Cardiac resuscitation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine in anesthetized dogs. Anesth Analg 2001;92:37-43.
23. Dony P, Dewinde V, Vanderick B, et al. The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats. Anesth Analg 2000;91:1489-92.
24. Lefrant JY, de La Coussaye JE, Ripart J, et al. The comparative electrophysiologic and hemodynamic effects of a large dose of ropivacaine and bupivacaine in anesthetized and ventilated piglets. Anesth Analg 2001;93:1598-605.
25. Bardsley H, Gristwood R, Baker H, et al. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1998;46:245-9.
26. Wyld PJ. A comparison of the effects of levobupivacaine and racemic bupivacaine on QT dispersion and signal averaged ECG in healthy male volunteers. Cambridge, UK, Chiroscience, Study Number 012105.
27. Rolan P. A two-Phase, double-Blind, three-way crossover study to compare the effects of racemic bupivacaine and levobupivacaine on the spectral components of the EEG. Cambridge, UK, Chiroscience, Study Number ME0400/NX007.
28. Knudsen K, Beckman Suurkula M, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997;78:507-14.
29. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989;69:563-9.
30. Ala-Kokko TI, Lopponen A, Alahuhta S. Two instances of central nervous system toxicity in the same patient following repeated ropivacaine-induced brachial plexus block. Acta Anaesthesiol Scand 2000;44:623-6.
31. Muller M, Litz RJ, Huler M, et al. Grand mal convulsion and plasma concentrations after intravascular injection of ropivacaine for axillary brachial plexus blockade. Br J Anaesth 2001;87:784-7.
32. Abouleish EI, Elias M, Nelson C. Ropivacaine-induced seizure after extradural anaesthesia. Br J Anaesth 1998;80:843-4.
33. Korman B, Riley RH. Convulsions induced by ropivacaine during interscalene brachial plexus block. Anesth Analg 1997;85:1128-9.
34. Plowman AN, Bolsin S, Mather LE. Central nervous system toxicity attributable to epidural ropivacaine hydrochloride. Anaesth Intensive Care 1998;26:204-6.
35. Selander D, Sjovall J, Tucker G. CNS toxicity of ropivacaine. Anaesth Intensive Care 1999;27:320-2.
36. Ruetsch YA, Fattinger KE, Borgeat A. Ropivacaine-induced convulsions and severe cardiac dysrhythmia after sciatic block. Anesthesiology 1999;90:1784-6.
37. Hawkins JL, Koonin LM, Palmer SK, et al. Anesthesia-related deaths during obstetric delivery in the United States, 1979-1990. Anesthesiology 1997;86:277-84.
38. D'Angelo R. Are the new local anesthetics worth their cost? Acta Anaesthesiol Scand 2000;44:639-41.
39. Bader AM, Datta S, Flanagan H, et al. Comparison of bupivacaine- and ropivacaine-induced conduction blockade in the isolated rabbit vagus nerve. Anesth Analg 1989;68:724-7.
40. Feldman HS, Covino BG. Comparative motor-blocking effects of bupivacaine and ropivacaine, a new amino amide local anesthetic, in the rat and dog. Anesth Analg 1988;67:1047-52.
41. Writer WD, Stienstra R, Eddleston JM, et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth 1998;81:713-7.
42. Dresner M, Freeman J, Calow C, et al. Ropivacaine 0.2% versus bupivacaine 0.1% with fentanyl: a double blind comparison for analgesia during labour. Br J Anaesth 2000;85:826-9.
43. Fernandez-Guisasola J, Serrano ML, Cobo B, et al. A comparison of 0.0625% bupivacaine with fentanyl and 0.1% ropivacaine with fentanyl for continuous epidural labor analgesia. Anesth Analg 2001;92:1261-5.
44. Fischer C, Blanie P, Jaouen E, et al. Ropivacaine, 0.1%, plus sufentanil, 0.5 microg/ml, versus bupivacaine, 0.1%, plus sufentanil, 0.5 microg/ml, using patient-controlled epidural analgesia for labor: a double-blind comparison. Anesthesiology 2000;92:1588-93.
45. Meister GC, D'Angelo R, Owen M, et al. A comparison of epidural analgesia with 0.125% ropivacaine with fentanyl versus 0.125% bupivacaine with fentanyl during labor. Anesth Analg 2000;90:632-7.
46. Owen MD, D'Angelo R, Gerancher JC, et al. 0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion. Anesth Analg 1998;86:527-31.
47. Owen MD, Thomas JA, Smith T, et al. Ropivacaine 0.075% and bupivacaine 0.075% with fentanyl 2 microg/mL are equivalent for labor epidural analgesia. Anesth Analg 2002;94:179-83.
48. Campbell DC, Zwack RM, Crone LA, et al. Ambulatory labor epidural analgesia: bupivacaine versus ropivacaine. Anesth Analg 2000;90:1384-9.
49. Eddleston JM, Holland JJ, Griffin RP, et al. A double-blind comparison of 0.25% ropivacaine and 0.25% bupivacaine for extradural analgesia in labour. Br J Anaesth 1996;76:66-71.
50. Gaiser RR, Venkateswaren P, Cheek TG, et al. Comparison of 0.25% ropivacaine and bupivacaine for epidural analgesia for labor and vaginal delivery. J Clin Anesth 1997;9:564-8.
51. Muir HA, Writer D, Douglas J, et al. Double-blind comparison of epidural ropivacaine 0.25% and bupivacaine 0.25%, for the relief of childbirth pain. Can J Anaesth 1997;44:599-604.
52. Stienstra R, Jonker TA, Bourdrez P, et al. Ropivacaine 0.25% versus bupivacaine 0.25% for continuous epidural analgesia in labor: a double-blind comparison. Anesth Analg 1995;80:285-9.
53. Crosby E, Sandier A, Finucane B, et al. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarean section. Can J Anaesth 1998;45:1066-71.
54. Datta S, Camann W, Bader A, et al. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology 1995;82:1346-52.
55. Griffin RP, Reynolds F. Extradural anaesthesia for caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth 1995;74:512-6.
56. Levin A, Datta S, Camann WR. Intrathecal ropivacaine for labor analgesia: a comparison with bupivacaine. Anesth Analg 1998;87:624-7.
57. Chung CJ, Choi SR, Yeo KH, et al. Hyperbaric spinal ropivacaine for cesarean delivery: a comparison to hyperbaric bupivacaine. Anesth Analg 2001;93:157-61.
58. Hughes D, Hill D, Fee JP. Intrathecal ropivacaine or bupivacaine with fentanyl for labour. Br J Anaesth 2001;87:733-7.
59. Bader AM, Tsen LC, Camann WR, et al. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999;90:1596-601.
60. Lyons G, Columb M, Wilson RC, et al. Epidural pain relief in labour: potencies of levobupivacaine and racemic bupivacaine. Br J Anaesth 1998;81:899-901.
61. Dixon WJ, Massey FJ. Introduction to Statistical Analyses. 4th edition. New York: McGraw-Hill; 1983. p. 428-39.
62. Polley LS, Columb MO, Naughton NN, et al. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: implications for therapeutic indexes. Anesthesiology 1999;90:944-50.
63. Capogna G, Celleno D, Fusco P, et al. Relative potencies of bupivacaine and ropivacaine for analgesia in labour. Br J Anaesth 1999;82:371-3.
64. Polley LS, Columb MO, Naughton NN, et al. Effect of intravenous versus epidural fentanyl on the minimum local analgesic concentration of epidural bupivacaine in labor. Anesthesiology 2000;93:122-8.
65. D'Angelo R, James RL. Is ropivacaine less potent than bupivacaine? Anesthesiology 1999;90:941-3.
66. Chua NP, Sia AT, Ocampo CE. Parturient-controlled epidural analgesia during labour: bupivacaine vs. ropivacaine. Anaesthesia 2001;56:1169-73.
67. Gautier P, De Kock M, Van Steenberge A, et al. A double-blind comparison of 0.125% ropivacaine with sufentanil and 0.125% bupivacaine with sufentanil for epidural labor analgesia. Anesthesiology 1999;90:772-8.
68. Dyhre H, Lang M, Wallin R, et al. The duration of action of bupivacaine, levobupivacaine, ropivacaine and pethidine in peripheral nerve block in the rat. Acta Anaesthesiol Scand 1997;41:1346-52.
69. Hawkins JL, Gibbs CP, Orleans M, et al. Obstetric anesthesia work force survey, 1981 versus 1992. Anesthesiology 1997;87:135-43.